Global IBS Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global IBS Treatment Market Size 2017-2028

2.1.2 IBS Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 IBS Treatment Segment by Type

2.2.1 IBS-D

2.2.2 IBS-C

2.2.3 IBS-M

2.3 IBS Treatment Market Size by Type

2.3.1 IBS Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global IBS Treatment Market Size Market Share by Type (2017-2022)

2.4 IBS Treatment Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Research Laboratories

2.5 IBS Treatment Market Size by Application

2.5.1 IBS Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global IBS Treatment Market Size Market Share by Application (2017-2022)

3 IBS Treatment Market Size by Player

3.1 IBS Treatment Market Size Market Share by Players

3.1.1 Global IBS Treatment Revenue by Players (2020-2022)

3.1.2 Global IBS Treatment Revenue Market Share by Players (2020-2022)

3.2 Global IBS Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 IBS Treatment by Regions

4.1 IBS Treatment Market Size by Regions (2017-2022)

4.2 Americas IBS Treatment Market Size Growth (2017-2022)

4.3 APAC IBS Treatment Market Size Growth (2017-2022)

4.4 Europe IBS Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa IBS Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas IBS Treatment Market Size by Country (2017-2022)

5.2 Americas IBS Treatment Market Size by Type (2017-2022)

5.3 Americas IBS Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC IBS Treatment Market Size by Region (2017-2022)

6.2 APAC IBS Treatment Market Size by Type (2017-2022)

6.3 APAC IBS Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe IBS Treatment by Country (2017-2022)

7.2 Europe IBS Treatment Market Size by Type (2017-2022)

7.3 Europe IBS Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa IBS Treatment by Region (2017-2022)

8.2 Middle East & Africa IBS Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa IBS Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global IBS Treatment Market Forecast

10.1 Global IBS Treatment Forecast by Regions (2023-2028)

10.1.1 Global IBS Treatment Forecast by Regions (2023-2028)

10.1.2 Americas IBS Treatment Forecast

10.1.3 APAC IBS Treatment Forecast

10.1.4 Europe IBS Treatment Forecast

10.1.5 Middle East & Africa IBS Treatment Forecast

10.2 Americas IBS Treatment Forecast by Country (2023-2028)

10.2.1 United States IBS Treatment Market Forecast

10.2.2 Canada IBS Treatment Market Forecast

10.2.3 Mexico IBS Treatment Market Forecast

10.2.4 Brazil IBS Treatment Market Forecast

10.3 APAC IBS Treatment Forecast by Region (2023-2028)

10.3.1 China IBS Treatment Market Forecast

10.3.2 Japan IBS Treatment Market Forecast

10.3.3 Korea IBS Treatment Market Forecast

10.3.4 Southeast Asia IBS Treatment Market Forecast

10.3.5 India IBS Treatment Market Forecast

10.3.6 Australia IBS Treatment Market Forecast

10.4 Europe IBS Treatment Forecast by Country (2023-2028)

10.4.1 Germany IBS Treatment Market Forecast

10.4.2 France IBS Treatment Market Forecast

10.4.3 UK IBS Treatment Market Forecast

10.4.4 Italy IBS Treatment Market Forecast

10.4.5 Russia IBS Treatment Market Forecast

10.5 Middle East & Africa IBS Treatment Forecast by Region (2023-2028)

10.5.1 Egypt IBS Treatment Market Forecast

10.5.2 South Africa IBS Treatment Market Forecast

10.5.3 Israel IBS Treatment Market Forecast

10.5.4 Turkey IBS Treatment Market Forecast

10.5.5 GCC Countries IBS Treatment Market Forecast

10.6 Global IBS Treatment Forecast by Type (2023-2028)

10.7 Global IBS Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Allergan (Ireland)

11.1.1 Allergan (Ireland) Company Information

11.1.2 Allergan (Ireland) IBS Treatment Product Offered

11.1.3 Allergan (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Allergan (Ireland) Main Business Overview

11.1.5 Allergan (Ireland) Latest Developments

11.2 Sucampo Pharmaceuticals (U.S.)

11.2.1 Sucampo Pharmaceuticals (U.S.) Company Information

11.2.2 Sucampo Pharmaceuticals (U.S.) IBS Treatment Product Offered

11.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sucampo Pharmaceuticals (U.S.) Main Business Overview

11.2.5 Sucampo Pharmaceuticals (U.S.) Latest Developments

11.3 Ironwood Pharmaceuticals (U.S.)

11.3.1 Ironwood Pharmaceuticals (U.S.) Company Information

11.3.2 Ironwood Pharmaceuticals (U.S.) IBS Treatment Product Offered

11.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Ironwood Pharmaceuticals (U.S.) Main Business Overview

11.3.5 Ironwood Pharmaceuticals (U.S.) Latest Developments

11.4 Astellas Pharma (Japan)

11.4.1 Astellas Pharma (Japan) Company Information

11.4.2 Astellas Pharma (Japan) IBS Treatment Product Offered

11.4.3 Astellas Pharma (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Astellas Pharma (Japan) Main Business Overview

11.4.5 Astellas Pharma (Japan) Latest Developments

11.5 Bausch Health

11.5.1 Bausch Health Company Information

11.5.2 Bausch Health IBS Treatment Product Offered

11.5.3 Bausch Health IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bausch Health Main Business Overview

11.5.5 Bausch Health Latest Developments

11.6 Abbott Laboratories (U.S.)

11.6.1 Abbott Laboratories (U.S.) Company Information

11.6.2 Abbott Laboratories (U.S.) IBS Treatment Product Offered

11.6.3 Abbott Laboratories (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Abbott Laboratories (U.S.) Main Business Overview

11.6.5 Abbott Laboratories (U.S.) Latest Developments

11.7 Synergy Pharmaceuticals (U.S.)

11.7.1 Synergy Pharmaceuticals (U.S.) Company Information

11.7.2 Synergy Pharmaceuticals (U.S.) IBS Treatment Product Offered

11.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Synergy Pharmaceuticals (U.S.) Main Business Overview

11.7.5 Synergy Pharmaceuticals (U.S.) Latest Developments

11.8 Ardelyx (U.S.)

11.8.1 Ardelyx (U.S.) Company Information

11.8.2 Ardelyx (U.S.) IBS Treatment Product Offered

11.8.3 Ardelyx (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ardelyx (U.S.) Main Business Overview

11.8.5 Ardelyx (U.S.) Latest Developments

11.9 Nestle (Switzerland)

11.9.1 Nestle (Switzerland) Company Information

11.9.2 Nestle (Switzerland) IBS Treatment Product Offered

11.9.3 Nestle (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Nestle (Switzerland) Main Business Overview

11.9.5 Nestle (Switzerland) Latest Developments

11.10 Sebela Pharmaceuticals (Ireland)

11.10.1 Sebela Pharmaceuticals (Ireland) Company Information

11.10.2 Sebela Pharmaceuticals (Ireland) IBS Treatment Product Offered

11.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sebela Pharmaceuticals (Ireland) Main Business Overview

11.10.5 Sebela Pharmaceuticals (Ireland) Latest Developments

11.11 Probi (Sweden)

11.11.1 Probi (Sweden) Company Information

11.11.2 Probi (Sweden) IBS Treatment Product Offered

11.11.3 Probi (Sweden) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Probi (Sweden) Main Business Overview

11.11.5 Probi (Sweden) Latest Developments

11.12 Alfasigma USA (Italy)

11.12.1 Alfasigma USA (Italy) Company Information

11.12.2 Alfasigma USA (Italy) IBS Treatment Product Offered

11.12.3 Alfasigma USA (Italy) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Alfasigma USA (Italy) Main Business Overview

11.12.5 Alfasigma USA (Italy) Latest Developments

11.13 RedHill Biopharma (Israel)

11.13.1 RedHill Biopharma (Israel) Company Information

11.13.2 RedHill Biopharma (Israel) IBS Treatment Product Offered

11.13.3 RedHill Biopharma (Israel) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 RedHill Biopharma (Israel) Main Business Overview

11.13.5 RedHill Biopharma (Israel) Latest Developments

11.14 AstraZeneca (U.K)

11.14.1 AstraZeneca (U.K) Company Information

11.14.2 AstraZeneca (U.K) IBS Treatment Product Offered

11.14.3 AstraZeneca (U.K) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 AstraZeneca (U.K) Main Business Overview

11.14.5 AstraZeneca (U.K) Latest Developments

11.15 Ipsen (France)

11.15.1 Ipsen (France) Company Information

11.15.2 Ipsen (France) IBS Treatment Product Offered

11.15.3 Ipsen (France) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Ipsen (France) Main Business Overview

11.15.5 Ipsen (France) Latest Developments

11.16 Novartis (Switzerland)

11.16.1 Novartis (Switzerland) Company Information

11.16.2 Novartis (Switzerland) IBS Treatment Product Offered

11.16.3 Novartis (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Novartis (Switzerland) Main Business Overview

11.16.5 Novartis (Switzerland) Latest Developments

11.17 Takeda Pharmaceutical Company (Japan)

11.17.1 Takeda Pharmaceutical Company (Japan) Company Information

11.17.2 Takeda Pharmaceutical Company (Japan) IBS Treatment Product Offered

11.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Takeda Pharmaceutical Company (Japan) Main Business Overview

11.17.5 Takeda Pharmaceutical Company (Japan) Latest Developments

11.18 Synthetic Biologics (U.S.)

11.18.1 Synthetic Biologics (U.S.) Company Information

11.18.2 Synthetic Biologics (U.S.) IBS Treatment Product Offered

11.18.3 Synthetic Biologics (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Synthetic Biologics (U.S.) Main Business Overview

11.18.5 Synthetic Biologics (U.S.) Latest Developments

11.19 Protagonist Therapeutics (U.S.)

11.19.1 Protagonist Therapeutics (U.S.) Company Information

11.19.2 Protagonist Therapeutics (U.S.) IBS Treatment Product Offered

11.19.3 Protagonist Therapeutics (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Protagonist Therapeutics (U.S.) Main Business Overview

11.19.5 Protagonist Therapeutics (U.S.) Latest Developments

11.20 Pfizer (U.S.)

11.20.1 Pfizer (U.S.) Company Information

11.20.2 Pfizer (U.S.) IBS Treatment Product Offered

11.20.3 Pfizer (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Pfizer (U.S.) Main Business Overview

11.20.5 Pfizer (U.S.) Latest Developments

11.21 Lexicon Pharmaceuticals (U.S.)

11.21.1 Lexicon Pharmaceuticals (U.S.) Company Information

11.21.2 Lexicon Pharmaceuticals (U.S.) IBS Treatment Product Offered

11.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Lexicon Pharmaceuticals (U.S.) Main Business Overview

11.21.5 Lexicon Pharmaceuticals (U.S.) Latest Developments

11.22 Innovate Biopharmaceuticals (U.S.)

11.22.1 Innovate Biopharmaceuticals (U.S.) Company Information

11.22.2 Innovate Biopharmaceuticals (U.S.) IBS Treatment Product Offered

11.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Innovate Biopharmaceuticals (U.S.) Main Business Overview

11.22.5 Innovate Biopharmaceuticals (U.S.) Latest Developments

12 Research Findings and Conclusion

Table 1. IBS Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of IBS-D

Table 3. Major Players of IBS-C

Table 4. Major Players of IBS-M

Table 5. IBS Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global IBS Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global IBS Treatment Market Size Market Share by Type (2017-2022)

Table 8. IBS Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global IBS Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global IBS Treatment Market Size Market Share by Application (2017-2022)

Table 11. Global IBS Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global IBS Treatment Revenue Market Share by Player (2020-2022)

Table 13. IBS Treatment Key Players Head office and Products Offered

Table 14. IBS Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global IBS Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global IBS Treatment Market Size Market Share by Regions (2017-2022)

Table 19. Americas IBS Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas IBS Treatment Market Size Market Share by Country (2017-2022)

Table 21. Americas IBS Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas IBS Treatment Market Size Market Share by Type (2017-2022)

Table 23. Americas IBS Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas IBS Treatment Market Size Market Share by Application (2017-2022)

Table 25. APAC IBS Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC IBS Treatment Market Size Market Share by Region (2017-2022)

Table 27. APAC IBS Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC IBS Treatment Market Size Market Share by Type (2017-2022)

Table 29. APAC IBS Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC IBS Treatment Market Size Market Share by Application (2017-2022)

Table 31. Europe IBS Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe IBS Treatment Market Size Market Share by Country (2017-2022)

Table 33. Europe IBS Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe IBS Treatment Market Size Market Share by Type (2017-2022)

Table 35. Europe IBS Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe IBS Treatment Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa IBS Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa IBS Treatment Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa IBS Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa IBS Treatment Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa IBS Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa IBS Treatment Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of IBS Treatment

Table 44. Key Market Challenges & Risks of IBS Treatment

Table 45. Key Industry Trends of IBS Treatment

Table 46. Global IBS Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global IBS Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global IBS Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global IBS Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global IBS Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global IBS Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 52. Allergan (Ireland) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 53. Allergan (Ireland) IBS Treatment Product Offered

Table 54. Allergan (Ireland) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Allergan (Ireland) Main Business

Table 56. Allergan (Ireland) Latest Developments

Table 57. Sucampo Pharmaceuticals (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 58. Sucampo Pharmaceuticals (U.S.) IBS Treatment Product Offered

Table 59. Sucampo Pharmaceuticals (U.S.) Main Business

Table 60. Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Sucampo Pharmaceuticals (U.S.) Latest Developments

Table 62. Ironwood Pharmaceuticals (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 63. Ironwood Pharmaceuticals (U.S.) IBS Treatment Product Offered

Table 64. Ironwood Pharmaceuticals (U.S.) Main Business

Table 65. Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Ironwood Pharmaceuticals (U.S.) Latest Developments

Table 67. Astellas Pharma (Japan) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 68. Astellas Pharma (Japan) IBS Treatment Product Offered

Table 69. Astellas Pharma (Japan) Main Business

Table 70. Astellas Pharma (Japan) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Astellas Pharma (Japan) Latest Developments

Table 72. Bausch Health Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 73. Bausch Health IBS Treatment Product Offered

Table 74. Bausch Health Main Business

Table 75. Bausch Health IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Bausch Health Latest Developments

Table 77. Abbott Laboratories (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 78. Abbott Laboratories (U.S.) IBS Treatment Product Offered

Table 79. Abbott Laboratories (U.S.) Main Business

Table 80. Abbott Laboratories (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Abbott Laboratories (U.S.) Latest Developments

Table 82. Synergy Pharmaceuticals (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 83. Synergy Pharmaceuticals (U.S.) IBS Treatment Product Offered

Table 84. Synergy Pharmaceuticals (U.S.) Main Business

Table 85. Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Synergy Pharmaceuticals (U.S.) Latest Developments

Table 87. Ardelyx (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 88. Ardelyx (U.S.) IBS Treatment Product Offered

Table 89. Ardelyx (U.S.) Main Business

Table 90. Ardelyx (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Ardelyx (U.S.) Latest Developments

Table 92. Nestle (Switzerland) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 93. Nestle (Switzerland) IBS Treatment Product Offered

Table 94. Nestle (Switzerland) Main Business

Table 95. Nestle (Switzerland) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Nestle (Switzerland) Latest Developments

Table 97. Sebela Pharmaceuticals (Ireland) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 98. Sebela Pharmaceuticals (Ireland) IBS Treatment Product Offered

Table 99. Sebela Pharmaceuticals (Ireland) Main Business

Table 100. Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Sebela Pharmaceuticals (Ireland) Latest Developments

Table 102. Probi (Sweden) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 103. Probi (Sweden) IBS Treatment Product Offered

Table 104. Probi (Sweden) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Probi (Sweden) Main Business

Table 106. Probi (Sweden) Latest Developments

Table 107. Alfasigma USA (Italy) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 108. Alfasigma USA (Italy) IBS Treatment Product Offered

Table 109. Alfasigma USA (Italy) Main Business

Table 110. Alfasigma USA (Italy) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Alfasigma USA (Italy) Latest Developments

Table 112. RedHill Biopharma (Israel) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 113. RedHill Biopharma (Israel) IBS Treatment Product Offered

Table 114. RedHill Biopharma (Israel) Main Business

Table 115. RedHill Biopharma (Israel) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. RedHill Biopharma (Israel) Latest Developments

Table 117. AstraZeneca (U.K) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 118. AstraZeneca (U.K) IBS Treatment Product Offered

Table 119. AstraZeneca (U.K) Main Business

Table 120. AstraZeneca (U.K) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. AstraZeneca (U.K) Latest Developments

Table 122. Ipsen (France) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 123. Ipsen (France) IBS Treatment Product Offered

Table 124. Ipsen (France) Main Business

Table 125. Ipsen (France) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Ipsen (France) Latest Developments

Table 127. Novartis (Switzerland) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 128. Novartis (Switzerland) IBS Treatment Product Offered

Table 129. Novartis (Switzerland) Main Business

Table 130. Novartis (Switzerland) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Novartis (Switzerland) Latest Developments

Table 132. Takeda Pharmaceutical Company (Japan) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 133. Takeda Pharmaceutical Company (Japan) IBS Treatment Product Offered

Table 134. Takeda Pharmaceutical Company (Japan) Main Business

Table 135. Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Takeda Pharmaceutical Company (Japan) Latest Developments

Table 137. Synthetic Biologics (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 138. Synthetic Biologics (U.S.) IBS Treatment Product Offered

Table 139. Synthetic Biologics (U.S.) Main Business

Table 140. Synthetic Biologics (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Synthetic Biologics (U.S.) Latest Developments

Table 142. Protagonist Therapeutics (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 143. Protagonist Therapeutics (U.S.) IBS Treatment Product Offered

Table 144. Protagonist Therapeutics (U.S.) Main Business

Table 145. Protagonist Therapeutics (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. Protagonist Therapeutics (U.S.) Latest Developments

Table 147. Pfizer (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 148. Pfizer (U.S.) IBS Treatment Product Offered

Table 149. Pfizer (U.S.) Main Business

Table 150. Pfizer (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. Pfizer (U.S.) Latest Developments

Table 152. Lexicon Pharmaceuticals (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 153. Lexicon Pharmaceuticals (U.S.) IBS Treatment Product Offered

Table 154. Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 155. Lexicon Pharmaceuticals (U.S.) Main Business

Table 156. Lexicon Pharmaceuticals (U.S.) Latest Developments

Table 157. Innovate Biopharmaceuticals (U.S.) Details, Company Type, IBS Treatment Area Served and Its Competitors

Table 158. Innovate Biopharmaceuticals (U.S.) IBS Treatment Product Offered

Table 159. Innovate Biopharmaceuticals (U.S.) Main Business

Table 160. Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 161. Innovate Biopharmaceuticals (U.S.) Latest Developments

List of Figures

Figure 1. IBS Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global IBS Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global IBS Treatment Market Size Market Share by Type in 2021

Figure 7. IBS Treatment in Hospitals

Figure 8. Global IBS Treatment Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. IBS Treatment in Clinics

Figure 10. Global IBS Treatment Market: Clinics (2017-2022) & ($ Millions)

Figure 11. IBS Treatment in Research Laboratories

Figure 12. Global IBS Treatment Market: Research Laboratories (2017-2022) & ($ Millions)

Figure 13. Global IBS Treatment Market Size Market Share by Application in 2021

Figure 14. Global IBS Treatment Revenue Market Share by Player in 2021

Figure 15. Global IBS Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas IBS Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC IBS Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe IBS Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa IBS Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas IBS Treatment Value Market Share by Country in 2021

Figure 21. Americas IBS Treatment Consumption Market Share by Type in 2021

Figure 22. Americas IBS Treatment Market Size Market Share by Application in 2021

Figure 23. United States IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC IBS Treatment Market Size Market Share by Region in 2021

Figure 28. APAC IBS Treatment Market Size Market Share by Application in 2021

Figure 29. China IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe IBS Treatment Market Size Market Share by Country in 2021

Figure 36. Europe IBS Treatment Market Size Market Share by Type in 2021

Figure 37. Europe IBS Treatment Market Size Market Share by Application in 2021

Figure 38. Germany IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa IBS Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa IBS Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa IBS Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country IBS Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey IBS Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries IBS Treatment Market Size 2023-2028 ($ Millions)